Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

BILIX

KAIST spin-off developing PEGylated bilirubin BX-001N to prevent acute kidney injury after cardiac surgery, now in phase 2a in Korea.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Customers 1
  • Investors 2
  • Peers 1

Customers1

Who could buy, or sell through

Buy Latin American real-world data to design phase 2b/3 and select sites

Phase 2b/3 design needs AKI incidence after cardiac surgery, baseline risk and site volumes. Cromodata's hospital network in five Latin American countries can supply de-identified cohorts and identify high-volume sites. Bilix gets cheaper trial design and new geographies; Cromodata gets a named pharma-type buyer.

30%confidence

Evidence from the records

  • “Marketplace in operation: claimed network of 47 to 84+ healthcare facilities in 5 countries (Argentina, Uruguay, Mexico, Dominican Rep., Brazil); no data buyer publicly named.”
  • “BX-001N: phase 1 completed (51 volunteers, Australia), phase 2a under way in Korea (NCT07164833) with KDDF support.”
If it works
A feasibility dataset and shortlisted LatAm sites for later trials.
First step
Send Cromodata a cohort definition (cardiac surgery, creatinine follow-up) and request a feasibility count.

Investors2

A fund whose thesis fits

Approach Sands Capital for the Series C, via PolyJoule

Sands Capital invests at Series A and later in biotech and medtech globally, matching Bilix's late-private stage. It is reported as an investor in PolyJoule in the network.

20%confidence

Evidence from the records

  • “Sands Capital Ventures and others (according to aggregators)”
  • “High risk: phase 2 clinical risk and large funding needs despite US$13M raised.”
If it works
A global growth-stage biotech investor for the post-phase-2a round.
First step
Ask PolyJoule's CEO for an intro to Sands Capital's life-science team.

Pitch EFung Capital, Pleryon's biotech investor

EFung invests at Series A and later in biotech in China and globally and backed Pleryon Therapeutics in the network; an Asian investor fits a Korean asset seeking regional licensing.

20%confidence

Evidence from the records

  • “EFung Capital (cited by CB Insights and Caplight); other historical investors: Zero2IPO, Kaitai Capital, Lapam Capital, HKUST R&D Corporation”
  • “Successful phase 1”
If it works
Capital plus access to Chinese licensing partners.
First step
Ask Pleryon's team for an intro to EFung Capital.

Peers1

Founders solving the same problem elsewhere

Exchange on polymer-drug CMC and Asian licensing

Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

20%confidence

Evidence from the records

  • “Proprietary platforms for designing and controlling the structure of large synthetic and modified natural polymers, for drug delivery and injectable biomaterials.”
  • “PEGylated bilirubin nanomedicine platform (antioxidant and immunomodulatory activity)”
If it works
Shared vendor lists and licensing introductions.
First step
Arrange a CEO call during the Grand Finale.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. VenditekwithPulster.aiCo-development

    Use Pulster NOVA to place and price every new machine

    Vending profitability is a location game, and Pulster sells site assessment and cannibalisation models to 49 Latin American retail brands from the same country. Venditek gets data-driven placement; Pulster gets a new micro-format use case and a joint offer to its retail clients.

    50%
  2. Piezo Sonic CorporationwithProxima RoboticsCo-development

    Run Proxima Compass on Mighty AMR

    Piezo Sonic's differentiation is the rough-terrain chassis and drive, not fleet software; Proxima sells a hardware-agnostic navigation and flow-management layer to robot makers. Bundling Compass on Mighty AMR gives Piezo a proven European navigation stack and gives Proxima an outdoor, all-terrain reference platform beyond indoor AGVs.

    50%
  3. Proxima RoboticswithPiezo Sonic CorporationCo-development

    Port Compass to Piezo Sonic's all-terrain AMR

    Piezo Sonic builds rough-terrain AMRs and sells through Japanese trading houses; Proxima sells navigation software. A port opens outdoor robotics and an Asian channel for Proxima.

    45%
  4. Thistle OÜwithOmniLoc AICo-development

    Integrate GPS-free localisation into Thistle Shield

    Counter-drone engagements happen where GPS is jammed or spoofed, often by the defender itself. OmniLoc's camera-to-satellite matching keeps autonomous platforms positioned without GPS, a direct building block for Thistle's autonomy and a field deployment for OmniLoc.

    40%
  5. RegenratewithFarmbookerCo-development

    Satellite monitoring of contracted fields

    Regenrate guarantees a price before sowing, so it carries yield risk across 1,000+ ha; satellite monitoring of each contracted field improves forecasting and agronomic support. Farmbooker supplies that layer.

    40%
  6. GreenirrwithLayrzCo-development

    Use Layrz's device-agnostic IoT cloud as the data-ingestion layer

    Greenirr needs telematics data from heterogeneous devices; Layrz already normalises many device brands through an API. An integration lets Greenirr onboard fleets in Latin America without custom connectors, and Layrz adds emissions analytics for its asset-tracking customers.

    40%
  7. IKI HealthwithHormonyCo-development

    Combine Hormony's saliva hormone kit with IKI prescriptions

    Menopause programmes need objective hormone data, which Hormony sells as a saliva kit; IKI turns data into clinician-prescribed programmes. A combined test-to-programme offer is stronger for both and opens cross-distribution between Spain and Hormony's markets.

    40%
  8. KetzaiwithMaria EducaçãoCo-development

    Plan-assess loop: Ketzai planning + Maria assessment

    Ketzai produces lesson plans; Maria Educação diagnoses student performance and builds learning paths for publishers and municipalities. Linking assessment results to lesson planning closes the loop that ministries buy, and gives Maria a Spanish-speaking entry route through Ketzai's teacher base.

    40%
  9. Starko OnewithPromptendCo-development

    Verify every Starko PR with deterministic checks

    Starko's promise is a verified pull request, and trust in AI code is the adoption bottleneck. Promptend checks behaviour of AI-generated TypeScript against a spec deterministically, a direct building block that strengthens Starko's claim and gives Promptend a distribution channel.

    40%
  10. ORA TechnologieswithThirdRocCo-development

    Plug ThirdRoc's pay-per-decision credit agents into the super-app

    Embedded credit is the main profit pool of a super-app, but ORA has no documented scoring capability. ThirdRoc sells AI credit decisioning, fraud detection and KYC paid per decision, which fits a variable-cost launch with a licensed Moroccan lender. ThirdRoc gains a North African deployment beyond Fiji.

    40%
  11. aimea.aiwithCoachbot AiCo-development

    From interview evidence to onboarding coaching

    aimea produces documented skills evidence at hiring; Coachbot turns coaching methodologies into AI coaching for HR/L&D. Passing aimea's gap analysis into a CoachBot onboarding plan creates a hire-to-develop offer for the same HR buyer, both Berlin/Hamburg-based.

    35%
  12. BelliwithLayrzCo-development

    Feed IoT asset telemetry into cargo status messaging

    Belli generates and parses IATA status messages; Layrz runs a device-agnostic IoT cloud for vehicles and assets. Wiring Layrz telematics (trucks, dollies, ULD trackers) into Belli's ontology would automate FSU-type status events and give carriers real-time visibility without manual scans, a feature legacy CMS vendors sell as costly add-ons.

    35%
  13. CromodatawithHardshellCo-development

    Certify datasets as leak- and poison-free

    Buyers of AI training data will require assurance against re-identification and contamination. Hardshell scans datasets for these risks; a 'verified' label increases Cromodata's price and trust.

    35%
  14. TerraSparkwithAstrolightCo-development

    Co-develop optical pointing and ground stations for power beaming

    Laser-based power beaming needs the same acquisition, pointing and tracking chain and ground-station know-how that Astrolight has flown. Astrolight gains a second application for its optical stack, while TerraSpark de-risks the transmission link with flight-proven hardware.

    35%
  15. Pleryon TherapeuticswithOcuwell LimitedCo-development

    Portable corneal imaging as a dry-eye trial endpoint

    Pleryon's dry-eye trial needs objective ocular-surface measures; Ocuwell's portable corneal topography device is already used by clinicians. Using OCUTOP in Pleryon's trial sites gives Pleryon richer endpoints and Ocuwell a pharma-trial use case.

    35%
  16. PraxilabswithHi DoctorCo-development

    Joint 'basic science to bedside' simulation bundle for medical schools

    Medical faculties buy both lab simulation (physiology, biochemistry) and clinical-reasoning simulation; PraxiLabs covers the first, Hi Doctor's AI virtual patients the second. A bundled offer raises deal size per faculty and gives each a reference in the other's region (MENA vs Central Asia).

    35%
  17. ProcureProwithSLZCo-development

    Turn MEP design models into procurement packages automatically

    MEP packages are among the most complex and costly to procure, especially on data centres and fabs. SLZ automates MEP design and maintains BIM-based digital twins; feeding SLZ quantities and routing into ProcurePro would pre-populate tender packages and track installed versus committed scope.

    35%
  18. PromptendwithStarko OneCo-development

    Verification gate in an AI feedback-to-PR pipeline

    Starko's AI builds accepted product changes all the way to a verified pull request; Promptend checks that generated TypeScript matches its spec. Embedding Promptend as Starko's verification step strengthens Starko's 'verified PR' promise and gives Promptend a production integration.

    35%
  19. Nanogrow BiotechwithLegit.HealthCo-development

    Use Legit.Health AI scoring as trial endpoints in psoriasis and AD

    Dermatology trials depend on severity scores that are subjective and costly to collect. Legit.Health provides CE-marked automated scoring and already partners with dermatology pharma, which could make Nanogrow's early trials cheaper and more credible to licensees.

    35%
  20. Viz Ai TechnologywithEthermindCo-development

    Capture retiring experts as AI twins on the shop floor

    Viz Ai's core thesis is the 'silver wave' of retiring mechanics; Ethermind builds AI twins of an organisation's best experts. Combining Viz Ai's in-job capture with Ethermind's knowledge-twin engine gives dealers a structured expertise base, not just repair logs.

    35%

Similar profiles

Compatibility score with BILIX

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.